Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,092)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Varex Imaging Corporation | VREX | $18.42 | $782.18M | 34.8 | — |
| Phreesia, Inc. | PHR | $12.26 | $760.99M | 72.1 | — |
| Iambic Therapeutics, Inc. | IAM | $15.80 | $748.93M | — | |
| Collegium Pharmaceutical, Inc. | COLL | $22.92 | $746.01M | 18.0 | — |
| Geron Corporation | GERN | $1.16 | $745.27M | — | |
| Annexon, Inc. | ANNX | $3.86 | $731.78M | — | |
| Adlai Nortye Group Ltd. | ANL | $11.26 | $725.12M | — | |
| Cytek Biosciences, Inc. | CTKB | $5.50 | $714.91M | — | |
| OmniAb, Inc. | OABI | $4.92 | $714.59M | — | |
| Candel Therapeutics, Inc. | CADL | $8.37 | $709.33M | — | |
| Sagimet Biosciences Inc. | SGMT | $9.99 | $708.38M | — | |
| Immix Biopharma, Inc. | IMMX | $8.51 | $705.50M | — | |
| Sana Biotechnology, Inc. | SANA | $2.35 | $703.50M | — | |
| 4D Molecular Therapeutics, Inc. | FDMT | $12.62 | $697.18M | — | |
| The Oncology Institute, Inc. | STLN | $6.83 | $696.09M | — | |
| Lexicon Pharmaceuticals, Inc. | LXRX | $1.56 | $694.13M | — | |
| Prime Medicine, Inc. | PRME | $3.81 | $691.05M | — | |
| Solid Biosciences Inc. | SLDB | $6.41 | $687.31M | — | |
| Pharming Group N.V. | PHAR | $9.65 | $683.01M | 74.2 | — |
| Nuvectis Pharma, Inc. | NVCT | $20.70 | $675.73M | — | |
| Ginkgo Bioworks Holdings, Inc. | DNA | $10.01 | $674.08M | — | |
| Design Therapeutics, Inc. | DSGN | $10.73 | $671.50M | — | |
| Achieve Life Sciences, Inc. | ACHV | $6.51 | $671.20M | — | |
| Aura Biosciences, Inc. | AURA | $6.46 | $669.93M | — | |
| Pacific Biosciences of California, Inc. | PACB | $2.14 | $665.18M | — | |
| Wave Life Sciences, Inc. | WVE | $3.37 | $664.05M | — | |
| Avalo Therapeutics, Inc. | AVTX | $12.26 | $657.50M | — | |
| Attovia Therapeutics, Inc. | ATTO | $14.18 | $647.33M | — | |
| Arbutus Biopharma Corporation | ABUS | $4.18 | $640.69M | 5.3 | — |
| SOPHiA GENETICS SA | SOPH | $7.35 | $625.69M | — | |
| Gyre Therapeutics, Inc. | GYRE | $5.90 | $625.60M | — | |
| OrthoPediatrics Corp. Common Stock | KIDS | $23.84 | $622.46M | — | |
| Olema Pharmaceuticals, Inc. | OLMA | $7.05 | $616.86M | — | |
| Zevra Therapeutics, Inc. | ZVRA | $10.36 | $615.22M | 10.9 | — |
| CorMedix Inc. | CRMD | $7.79 | $607.19M | 3.8 | — |
| DBV Technologies S.A. | DBVT | $9.62 | $604.60M | — | |
| Weave Communications, Inc. | WEAV | $7.39 | $594.53M | — | |
| Climb Bio, Inc. | CLYM | $10.87 | $592.17M | — | |
| Ironwood Pharmaceuticals, Inc. | IRWD | $3.55 | $586.60M | 4.6 | — |
| Anteris Technologies Global Corp. | AVR | $6.01 | $585.73M | — | |
| ProKidney Corp. | PROK | $1.44 | $574.82M | — | |
| Phathom Pharmaceuticals, Inc. | PHAT | $7.03 | $568.73M | — | |
| Electra Therapeutics, Inc. Common stock | ETRA | $9.05 | $568.04M | — | |
| Puma Biotechnology, Inc. | PBYI | $10.90 | $562.66M | 21.4 | — |
| GMR Solutions Inc. | GMRS | $10.40 | $561.83M | — | |
| Aclaris Therapeutics, Inc. | ACRS | $3.81 | $560.83M | — | |
| Shattuck Labs, Inc. | STTK | $5.58 | $560.03M | — | |
| Evotec SE | EVO | $1.56 | $554.41M | — | |
| Fulgent Genetics, Inc. | FLGT | $20.13 | $553.88M | — | |
| Evolent Health, Inc. | EVH | $4.83 | $546.08M | — |
Varex Imaging Corporation
Healthcare / Medical Devices
- Market Cap
- $782.18M
- P/E
- 34.8
Phreesia, Inc.
Healthcare / Health Information Services
- Market Cap
- $760.99M
- P/E
- 72.1
Iambic Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $748.93M
- P/E
- unprofitable
Collegium Pharmaceutical, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $746.01M
- P/E
- 18.0
Geron Corporation
Healthcare / Biotechnology
- Market Cap
- $745.27M
- P/E
- unprofitable
Annexon, Inc.
Healthcare / Biotechnology
- Market Cap
- $731.78M
- P/E
- unprofitable
Adlai Nortye Group Ltd.
Healthcare / Biotechnology
- Market Cap
- $725.12M
- P/E
- unprofitable
Cytek Biosciences, Inc.
Healthcare / Medical Devices
- Market Cap
- $714.91M
- P/E
- unprofitable
OmniAb, Inc.
Healthcare / Biotechnology
- Market Cap
- $714.59M
- P/E
- unprofitable
Candel Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $709.33M
- P/E
- unprofitable
Sagimet Biosciences Inc.
Healthcare / Biotechnology
- Market Cap
- $708.38M
- P/E
- unprofitable
Immix Biopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $705.50M
- P/E
- unprofitable
Sana Biotechnology, Inc.
Healthcare / Biotechnology
- Market Cap
- $703.50M
- P/E
- unprofitable
4D Molecular Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $697.18M
- P/E
- unprofitable
The Oncology Institute, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $696.09M
- P/E
- unprofitable
Lexicon Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $694.13M
- P/E
- unprofitable
Prime Medicine, Inc.
Healthcare / Biotechnology
- Market Cap
- $691.05M
- P/E
- unprofitable
Solid Biosciences Inc.
Healthcare / Biotechnology
- Market Cap
- $687.31M
- P/E
- unprofitable
Pharming Group N.V.
Healthcare / Biotechnology
- Market Cap
- $683.01M
- P/E
- 74.2
Nuvectis Pharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $675.73M
- P/E
- unprofitable
Ginkgo Bioworks Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $674.08M
- P/E
- unprofitable
Design Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $671.50M
- P/E
- unprofitable
Achieve Life Sciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $671.20M
- P/E
- unprofitable
Aura Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $669.93M
- P/E
- unprofitable
Pacific Biosciences of California, Inc.
Healthcare / Medical Devices
- Market Cap
- $665.18M
- P/E
- unprofitable
Wave Life Sciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $664.05M
- P/E
- unprofitable
Avalo Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $657.50M
- P/E
- unprofitable
Attovia Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $647.33M
- P/E
- unprofitable
Arbutus Biopharma Corporation
Healthcare / Biotechnology
- Market Cap
- $640.69M
- P/E
- 5.3
SOPHiA GENETICS SA
Healthcare / Health Information Services
- Market Cap
- $625.69M
- P/E
- unprofitable
Gyre Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $625.60M
- P/E
- unprofitable
OrthoPediatrics Corp. Common Stock
Healthcare / Medical Devices
- Market Cap
- $622.46M
- P/E
- unprofitable
Olema Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $616.86M
- P/E
- unprofitable
Zevra Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $615.22M
- P/E
- 10.9
CorMedix Inc.
Healthcare / Biotechnology
- Market Cap
- $607.19M
- P/E
- 3.8
DBV Technologies S.A.
Healthcare / Biotechnology
- Market Cap
- $604.60M
- P/E
- unprofitable
Weave Communications, Inc.
Healthcare / Health Information Services
- Market Cap
- $594.53M
- P/E
- unprofitable
Climb Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $592.17M
- P/E
- unprofitable
Ironwood Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $586.60M
- P/E
- 4.6
Anteris Technologies Global Corp.
Healthcare / Medical Devices
- Market Cap
- $585.73M
- P/E
- unprofitable
ProKidney Corp.
Healthcare / Biotechnology
- Market Cap
- $574.82M
- P/E
- unprofitable
Phathom Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $568.73M
- P/E
- unprofitable
Electra Therapeutics, Inc. Common stock
Healthcare / Biotechnology
- Market Cap
- $568.04M
- P/E
- unprofitable
Puma Biotechnology, Inc.
Healthcare / Biotechnology
- Market Cap
- $562.66M
- P/E
- 21.4
GMR Solutions Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $561.83M
- P/E
- unprofitable
Aclaris Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $560.83M
- P/E
- unprofitable
Shattuck Labs, Inc.
Healthcare / Biotechnology
- Market Cap
- $560.03M
- P/E
- unprofitable
Evotec SE
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $554.41M
- P/E
- unprofitable
Fulgent Genetics, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $553.88M
- P/E
- unprofitable
Evolent Health, Inc.
Healthcare / Health Information Services
- Market Cap
- $546.08M
- P/E
- unprofitable
Showing 401–450 of 1,092 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.